Farzaneh Sabahi

1.0k total citations
72 papers, 852 citations indexed

About

Farzaneh Sabahi is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Farzaneh Sabahi has authored 72 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Epidemiology, 31 papers in Hepatology and 19 papers in Infectious Diseases. Recurrent topics in Farzaneh Sabahi's work include Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (26 papers) and Herpesvirus Infections and Treatments (13 papers). Farzaneh Sabahi is often cited by papers focused on Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (26 papers) and Herpesvirus Infections and Treatments (13 papers). Farzaneh Sabahi collaborates with scholars based in Iran, Sweden and Germany. Farzaneh Sabahi's co-authors include Samad Amini‐Bavil‐Olyaee, Ramin Sarrami‐Forooshani, Ahmad Adeli, Mohammad Reza Zali, Fereidoun Mahboudi, Mohammad Azizi, Seyed Moayed Alavian, Roya Yaraee, Abolhassan Ahmadiani and Massoumeh Ebtekar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Clinical Microbiology and Infection.

In The Last Decade

Farzaneh Sabahi

68 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farzaneh Sabahi Iran 16 541 437 164 125 113 72 852
Mélanie Lambotin France 10 211 0.4× 185 0.4× 52 0.3× 171 1.4× 77 0.7× 13 482
Timokratis Karamitros Greece 17 192 0.4× 79 0.2× 189 1.2× 56 0.4× 261 2.3× 38 651
Liane Agulto United States 6 144 0.3× 82 0.2× 136 0.8× 137 1.1× 110 1.0× 9 493
Eiji Ono Japan 13 235 0.4× 108 0.2× 44 0.3× 58 0.5× 89 0.8× 53 487
Jonas Michel Wolf Brazil 14 260 0.5× 72 0.2× 119 0.7× 48 0.4× 210 1.9× 59 660
W. Sonnabend Switzerland 8 266 0.5× 156 0.4× 74 0.5× 45 0.4× 57 0.5× 31 625
D L Tyrrell Canada 13 459 0.8× 68 0.2× 138 0.8× 63 0.5× 175 1.5× 21 714
Abdolamir Landi Canada 12 132 0.2× 138 0.3× 57 0.3× 182 1.5× 119 1.1× 18 448
Isabelle Garrigue France 24 925 1.7× 80 0.2× 435 2.7× 501 4.0× 137 1.2× 56 1.7k
Jean‐Pierre Gut France 15 297 0.5× 111 0.3× 158 1.0× 106 0.8× 103 0.9× 48 607

Countries citing papers authored by Farzaneh Sabahi

Since Specialization
Citations

This map shows the geographic impact of Farzaneh Sabahi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzaneh Sabahi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzaneh Sabahi more than expected).

Fields of papers citing papers by Farzaneh Sabahi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzaneh Sabahi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzaneh Sabahi. The network helps show where Farzaneh Sabahi may publish in the future.

Co-authorship network of co-authors of Farzaneh Sabahi

This figure shows the co-authorship network connecting the top 25 collaborators of Farzaneh Sabahi. A scholar is included among the top collaborators of Farzaneh Sabahi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzaneh Sabahi. Farzaneh Sabahi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pouriayevali, Mohammad Hassan, Taravat Bamdad, Seyed Mehdi Sadat, et al.. (2019). Listeriolysin O immunogenetic adjuvant enhanced potency of hepatitis C virus NS3 DNA vaccine. IUBMB Life. 71(10). 1645–1652. 10 indexed citations
2.
Sabahi, Farzaneh, et al.. (2018). Effects of Rhus Coriaria L. (Sumac) Extract on Hepatitis B Virus Replication and Hbs Ag Secretion. Journal of Reports in Pharmaceutical Sciences. 7(1). 100–107. 2 indexed citations
3.
Sabahi, Farzaneh, et al.. (2017). IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo. Archives of Virology. 163(4). 877–886. 4 indexed citations
4.
Sabahi, Farzaneh, et al.. (2016). Lack of association between Interleukin-12 gene polymorphism (rs568408 G/A) and susceptibility to chronic hepatitis B virus infection. 20(1). 21–25.
5.
Pouriayevali, Mohammad Hassan, Taravat Bamdad, Seyed Mehdi Sadat, Farzaneh Sabahi, & Mohammad Reza Aghasadeghi. (2016). Construction of pLLO vector encoding truncated form of Listeriolysin O as molecular adjuvant for DNA vaccine studies. 2(3). 1 indexed citations
6.
Nasab, Seyed Dawood Mousavi, Farzaneh Sabahi, Manoochehr Makvandi, et al.. (2016). Epidemiology of Rotavirus-Norovirus Co-Infection and Determination of Norovirus Genogrouping among Children with Acute Gastroenteritis in Tehran, Iran.. PubMed. 20(5). 280–6. 22 indexed citations
7.
Sabahi, Farzaneh, et al.. (2014). HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A. Hepatitis Monthly. 14(4). e17822–e17822. 5 indexed citations
8.
Kheiri, Masoumeh Tavassoti, et al.. (2012). Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge. Antiviral Research. 95(3). 229–236. 13 indexed citations
9.
Ravanshad, Mehrdad, et al.. (2011). Prediction of hepatitis B virus lamivudine resistance based on YMDD sequence data using an artificial neural network model. Hepatitis Monthly. 11(231). 108–113. 5 indexed citations
10.
Sabahi, Farzaneh, et al.. (2011). CLONING AND EVALUATION OF EXPRESSION OF A NOVEL OVERLAPPING REGION OF NS3 GENE OF HEPATITIS C VIRUS BY EXPRESSING VECTOR. 13(4). 21–32.
11.
Zali, Narges, et al.. (2009). An Extremely Aberrant Subtype of Hepatitis B Virus Genotype D in Iran. Hepatitis Monthly. 9(122). 73–75. 4 indexed citations
12.
Amini‐Bavil‐Olyaee, Samad, Ulf Herbers, Seyed Reza Mohebbi, et al.. (2009). Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome. Journal of Hepatology. 51(4). 647–654. 23 indexed citations
13.
Ziyaeyan, Mazyar & Farzaneh Sabahi. (2008). HUMAN CYTOMEGALOVIRUS: INFECTIONS AND DIAGNOSIS. Iranian journal of medical sciences. 33(3). 127–132. 1 indexed citations
14.
15.
Ravanshad, Mehrdad, et al.. (2006). A RAPID MODIFIED ANTIBODY-CAPTURE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION HSV-1 PRIMARY INFECTION IN HUMAN. Shiraz E-Medical Journal. 7(2). 0–0.
16.
Sabahi, Farzaneh, et al.. (2006). Determination of HCV Genotypes in Iranian Isolates by PCR-RFLP. SHILAP Revista de lepidopterología. 12 indexed citations
17.
Ziyaeyan, Mazyar, Farzaneh Sabahi, Abdolvahab Alborzi, et al.. (2006). Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.. PubMed. 4(1). 470–4. 5 indexed citations
18.
Ziyaeyan, Mazyar, Farzaneh Sabahi, Abdolvahab Alborzi, et al.. (2005). DEVELOPMENT OF A SENSITIVE QUANTITATIVE COMPETITIVE PCR ASSAY FOR DETECTION OF HUMAN CYTOMEGALOVIRUS DNA. 9(4). 187–191. 1 indexed citations
19.
Sabahi, Farzaneh, et al.. (2003). PCR OPTIMIZATION: IMPROVING OF HUMAN CYTOMEGALOVIRUS (HCMV) PCRTO ACHIEVE A HIGHLY SENSITIVE DETECTION METHOD†. Iranian Journal of Biotechnology. 1(1). 59–64. 5 indexed citations
20.
Sabahi, Farzaneh, et al.. (2003). Growth and isolation of Human cytomegalovirus on a new human fetal foreskin fibroblast-derived cell line in Iran. Iranian Journal of Biotechnology. 1(4). 247–251. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mélanie Lambotin Breakdown of academic impact, for papers by Timokratis Karamitros Breakdown of academic impact, for papers by Liane Agulto Breakdown of academic impact, for papers by Eiji Ono Breakdown of academic impact, for papers by Jonas Michel Wolf Breakdown of academic impact, for papers by W. Sonnabend Breakdown of academic impact, for papers by D L Tyrrell Breakdown of academic impact, for papers by Abdolamir Landi Breakdown of academic impact, for papers by Isabelle Garrigue Breakdown of academic impact, for papers by Jean‐Pierre Gut
Rankless by CCL
2026